These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 326542)

  • 1. Valproate sodium: a controlled clinical trial including monitoring of drug levels.
    Gram L; Wulff K; Rasmussen KE; Flachs H; Würtz-Jorgensen A; Sommerbeck KW; Lohren V
    Epilepsia; 1977 Jun; 18(2):141-8. PubMed ID: 326542
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlled trial of sodium valproate in severe epilepsy.
    Richens A; Ahmad S
    Br Med J; 1975 Nov; 4(5991):255-6. PubMed ID: 1104059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter: Sodium valproate in the treatment of intractable childhood epilepsy.
    Coulthard MG
    Dev Med Child Neurol; 1975 Aug; 17(4):534. PubMed ID: 1098952
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sodium di-n-propylacetate, effect in the treatment of resistant epilepsy. A controlled study].
    Gram L; Wulff K; Rasmussen KE; Flachs H; Würtz-Jørgensen A; Sommerbeck KW; Løhren V
    Ugeskr Laeger; 1977 May; 139(18):1064-9. PubMed ID: 324058
    [No Abstract]   [Full Text] [Related]  

  • 5. [Double-blind study on the anti-convulsive effect of phenobarbital and valproate in the Lennox syndrome].
    Vassella F; Rüdeberg A; Da Silva V; Pavlincova E
    Schweiz Med Wochenschr; 1978 May; 108(19):713-6. PubMed ID: 347569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experiences with sodium 2-propyl valerate (Depakine) in the treatment of epilepsy].
    Trompetter-van Woerden ML; van der Zwan A
    Ned Tijdschr Geneeskd; 1977 Apr; 121(14):578-90. PubMed ID: 323732
    [No Abstract]   [Full Text] [Related]  

  • 7. Sodium valproate in the treatment of intractable childhood epilepsy.
    Barnes SE; Bower BD
    Dev Med Child Neurol; 1975 Apr; 17(2):175-81. PubMed ID: 1093915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: A controlled trial of sodium valproate in severe epilepsy.
    Richens A
    Electroencephalogr Clin Neurophysiol; 1975 Oct; 39(4):428. PubMed ID: 51730
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sodium di-n-propylacetate: evaluation of its so-called psychotropic effect. A controlled study].
    Sommerbeck KW; Theilgaard A; Rasmussen KE; Løhren V; Gram L; Wulff K
    Ugeskr Laeger; 1977 May; 139(18):1069-73. PubMed ID: 324059
    [No Abstract]   [Full Text] [Related]  

  • 10. Withdrawal symptoms from phenytoin, carbamazepine and sodium valproate.
    Duncan JS; Shorvon SD; Trimble MR
    J Neurol Neurosurg Psychiatry; 1988 Jul; 51(7):924-8. PubMed ID: 3144581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of childhood epilepsy with sodium valproate.
    Haigh D; Forsythe WI
    Dev Med Child Neurol; 1975 Dec; 17(6):743-8. PubMed ID: 812750
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevation of diphenylhydantoin and primidone serum concentration by addition of dipropylacetate, a new anticonvulsant drug.
    Windorfer A; Sauer W; Gädeke R
    Acta Paediatr Scand; 1975 Sep; 64(5):771-2. PubMed ID: 1101639
    [No Abstract]   [Full Text] [Related]  

  • 13. [Trial of a new antiepileptic drug, magnesium dipropyl acetate].
    de Pasquet EG; Gomensoro JB; de Bustos LF; Tenzer SM
    Acta Neurol Latinoam; 1973; 19(1-4):119-28. PubMed ID: 4619958
    [No Abstract]   [Full Text] [Related]  

  • 14. Sodium valproate in the treatment of resistant epilepsy.
    Hassan MN; Laljee HC; Parsonage MJ
    Acta Neurol Scand; 1976 Sep; 54(3):209-218. PubMed ID: 822682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anticonvulsant effect of sodium valproate and clonazepam in the management of intractable epilepsy.
    Lance JW; Anthony M
    Trans Am Neurol Assoc; 1976; 101():200-4. PubMed ID: 800689
    [No Abstract]   [Full Text] [Related]  

  • 16. [Valproic acid in the treatment of epilepsy with special emphasis on serum level determination (author's transl)].
    Fröscher W; Schulz HU; Gugler R
    Fortschr Neurol Psychiatr Grenzgeb; 1978 Jun; 46(6):327-41. PubMed ID: 352872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical--pharmacological aspects of treatment with sodium di-n-propylacetate].
    Wulff K; Flachs H; Würtz-Jørgensen A; Gram L
    Ugeskr Laeger; 1977 May; 139(18):1059-64. PubMed ID: 324057
    [No Abstract]   [Full Text] [Related]  

  • 18. Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy.
    Pinder RM; Brogden RN; Speight TM; Avery GS
    Drugs; 1977 Feb; 13(2):81-123. PubMed ID: 402258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium valproate in epilepsy.
    Lancet; 1977 Oct; 2(8043):860. PubMed ID: 72202
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: Preliminary experience with sodium valproate.
    Ronthal M
    S Afr Med J; 1975 Jun; 49(27):1077. PubMed ID: 1098174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.